Peritoneal dialysisย market was valued at $3,213 million in 2017, and is expected to reach $5,074 million by 2025, growing at a CAGR of 5.8% from 2018 to 2025.

Peritoneal dialysis (PD) is a treatment that uses the inner lining of abdomen, called the peritoneum and a dialysis solution to purify blood when the kidneys are not functioning adequately. PD is performed manually or via automated systems. Increase in prevalence of ESRD, growth in demand for home dialysis treatment and technological advancement in cyclers & PD devices are driving the market growth. In addition, peritoneal dialysis offers some advantages, such as needle free treatment, portability, treatment convenience, and less dietary restrictions that further fuel the market growth globally. However, risk associated with peritoneal dialysis such as peritonitis, infection, weight gain, and hernia is expected to negatively impact the growth of the peritoneal dialysis market.

๐‹๐ข๐ฌ๐ญ ๐จ๐Ÿ ๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ :

  • Baxter International Inc
  • Cook Medical Inc
  • Fresenius Medical Care AG & Co. KGaA
  • Medtronic Plc
  • Medionics International, Inc
  • Newsol Technologies Inc
  • Poly Medicure Ltd
  • Renax Biomedical Tech. Co., Ltd
  • Terumo Corporation
  • Utah Medical Products, Inc


๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/4651


๐†๐ž๐ญ ๐”๐ฉ ๐“๐จ ๐Ÿ๐ŸŽ% ๐ƒ๐ข๐ฌ๐œ๐จ๐ฎ๐ง๐ญ, ๐“๐ข๐ฅ๐ฅ ๐ญ๐ก๐ž ๐ƒ๐š๐ญ๐ž ๐Ÿ๐ŸŽ๐ญ๐ก ๐จ๐Ÿ ๐€๐ฎ๐ ๐ฎ๐ฌ๐ญ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ.


Peritoneal dialysis is performed by using machines or via manual method. Based on treatment type, market is segmented as continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD). At present, CAPD is a major revenue generating segment due to lower cost, portability, and freedom from machines. On the other side, APD is projected to show fastest market growth during the forecast period owing to its advantages such as flexibility with daytime routine, safety, and convenience.

Based on product, the market is categorized as peritoneal dialysis solution, device, peritoneal dialysis set, catheter, others. Presently, peritoneal dialysis solution segment is a major revenue contributor and is anticipated to maintain its dominance during the forecast period. Peritoneal dialysis solution plays a vital role in every PD procedure as these solutions facilitate exchange of fluid to remove waste products from body. However, devices segment is anticipated to show fastest market growth, due to the technological advancement in devices and increase in demand for automated peritoneal dialysis (APD).

Based on end user, home based dialysis occupied the largest share in 2017, and is anticipated to continue its dominance during the forecast period, due to availability of dialysis machines with greater convenience and better clinical outcomes for homecare use. Furthermore, increase in demand for home healthcare among dialysis patients further drives the growth of home based dialysis segment.


๐…๐จ๐ซ ๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/4651


๐Š๐„๐˜ ๐…๐ˆ๐๐ƒ๐ˆ๐๐†๐’ ๐Ž๐… ๐“๐‡๐„ ๐’๐“๐”๐ƒ๐˜

  • Based on treatment, the automated peritoneal dialysis (APD) segment is expected to show the fastest market growth, and is expected to grow at a CAGR of 6.7% from 2018 to 2025.
  • Based on product, peritoneal dialysis solution segment held more than one-third share in 2017 and is expected to remain dominant throughout the forecast period.
  • Based on end user, the home-based dialysis held more than two-third of the global market share in 2017 and is expected to remain dominant throughout the forecast period.
  • Based on region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 6.9% during the forecast period.


๐Ž๐ญ๐ก๐ž๐ซ ๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ:

ENT and Bronchoscopy Devices Market

Vascular Graft Market

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โ€œMarket Research Reportsโ€ and โ€œBusiness Intelligence Solutions.โ€ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

Leave a comment

Your email address will not be published. Required fields are marked *